Healthcare: GW Pharma Poised for First FDA Marijuana Approval
Industry Focus - Un pódcast de The Motley Fool
Categorías:
Promo: GW Pharmaceuticals scores a big thumbs up from a panel of FDA experts for its marijuana-based drug. Plus, Biogen pays a $1 billion dollars for expanded access to Ionis’ novel pipeline.
